Pluriglandular Syndrome with Hyperinsulinism. Cardiomegaly as a Possible Complication of Diazoxide Therapy
نویسندگان
چکیده
منابع مشابه
Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
Case presentation A baby boy with birth weight of 2.4kg at 35 weeks was born via Caesarian section. The boy was allowed feeding on demands, however he had the first onset of hypoglycemia at 2 hours of life. His blood sugar ranged from low reading to 2.5 mmol/L. The patient was treated with boluses of intravenous dextrose D10% followed by maintenance dextrose with its increasing strength in orde...
متن کاملIliacus haematoma syndrome as a complication of anticoagulant therapy.
Medical Memoranda BRrT= 97 She made an uneventful postoperative recovery, and when seen in the outpatient department four months later was well and menstruation had returned to normal. Histology.-By comparison with placentae belonging to embryos of known size the histology corresponds most closely to those of 10 to 15-mm. (37 to 42-day) embryos as regards the characteristics of the cytotrophobl...
متن کاملEndoscopic Sphingterotomy as A Therapy of Patients with Postoperative Complication of Cholecystectomy(Retrospective Study of 34 Patients in a Year)
Gallstones are among common complaints of human societies. Its prevalence has been estimated about 10% in western societies. As operational manipulation is still the method of choice in symptomatic gallstones, post-operative side effects and complaints, like remained gallstone in common bile duct, are studied. In a retrospective study we have reviewed the files of the patients hospitalized in S...
متن کاملassessment of the effect of honey as a topical therapy for intra oral wound healing in rat.
چکیده ندارد.
15 صفحه اولCongenital hyperinsulinism: clinical and molecular characterisation of compound heterozygous ABCC8 mutation responsive to Diazoxide therapy
BACKGROUND Mutations in ABCC8 and KCNJ11 are the most common cause of congenital hyperinsulinism (CHI). Recessive as well as dominant acting ABCC8/KCNJ11 mutations have been described. Diazoxide, which is the first line medication for CHI, is usually ineffective in recessive ABCC8 mutations. We describe the clinical and molecular characterisation of a recessive ABCC8 mutation in a CHI patient t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Proceedings of the Royal Society of Medicine
سال: 1968
ISSN: 0035-9157
DOI: 10.1177/003591576806101203